Caplin Point Laboratories Ltd — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Caplin Point Laboratories Ltd holds 70.57% of the company. At a market capitalisation of ₹17.98k cr, that holding is worth ₹12.69k cr.

Promoter stake

70.57%

Value of holding

₹12.69k cr

Market cap

₹17.98k cr

Stake change

+1.54%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
69.03%—
Q4-2021
68.91%—
Q1-2022
68.89%—
Q2-2022
68.88%—
Q3-2022
68.88%—
Q4-2022
68.80%—
Q1-2023
70.66%—
Q2-2023
70.63%—
Q3-2023
70.63%—
Q4-2023
70.62%—
Q1-2024
70.62%—
Q2-2024
70.56%—
Q3-2024
70.56%—
Q4-2024
70.56%—
Q1-2025
70.56%—
Q2-2025
70.56%—
Q3-2025
70.57%—
Q4-2025
70.57%—
Q1-2026
70.57%—
Q2-2026
70.57%—
Q3-2026
70.57%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Caplin Point Laboratories Ltd's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.